Cardiology

The study of more than 1.9 million US residents is the first to investigate a link between both full and partial COVID-19 vaccination and future CV risk.

Foods that are "engineered" with refined carbohydrates and fats that are rapidly absorbed can lead to cravings on par with those for alcohol and nicotine, says Ashley Gearhardt, PhD.

A new review found that menopausal hormone therapy for vasomotor symptoms is safe and appropriate for most women at low atherosclerotic cardiovascular disease risk.

The magnitude of the association with age did not change, however, for other stroke risk factors, including smoking, atrial fibrillation, and LVH, investigators report.

Sleep duration irregularity was associated with measures of subclinical atherosclerosis in a racially and ethnically diverse study of more than 2000 adults.

The DASH diet, Mediterranean diet, and Flexitarian diet top the list of 10 best diets for cardiovascular health as ranked by US News and World Report.

All pregnant persons should have BP measured at each prenatal visit to prevent complications of hypertension disorders, says the USPSTF.

Your daily dose of clinical news you may have missed.

Differences in cardiometabolic health between IVF- and naturally-conceived children were small and not statistically significant in the largest study of its kind.

Researchers found that Black and Hispanic Americans were less likely to be treated for certain poststroke complications, such as mood and spasticity, compared to White adults.

Your daily dose of clinical news you may have missed.

A study of more than 1.5 million women with a history of preeclampsia found up to a 4-fold higher risk of MI and 3-fold increased risk of stroke within 10 years of delivery.

Your daily dose of clinical news you may have missed.

A 2-sample Mendelian randomization analysis showed that sleep apnea and snoring increased the risk of HTN and CAD, and these associations may partly be driven by BMI.

A pivotal study with 40-year follow-up of post-bariatric surgery patients reinforces long-term benefits of the procedures on all-cause and cause-specific mortality.

Your daily dose of clinical news you may have missed.

After hospital discharge for heart failure, adults treated with either furosemide or torsemide had similar mortality rates, according to results from the TRANSFORM-HF clinical trial.

For each cardiometabolic disease, the risk of all-cause dementia rose by 42%; the risk rose 26% for Alzheimer disease and 64% for vascular dementia. Temporal onset and genetics play key roles.

Adolescents with more positive psychological assets were more likely to have good cardiometabolic health 2 decades later, and associations were stronger for Black youth.

Your daily dose of clinical news you may have missed.

Adherence to several different healthy eating patterns was associated with reduced risk for all- and specific-cause mortality in a large prospective cohort study with 36 years of follow-up.

Findings elaborate on the pathophysiological differences in autoimmunity and atrial fibrillation risk between men and women.

Optimal glycemic control (less than 7%) in participants from the Look AHEAD trial was associated with smaller increases in frailty index score vs poorer control over the 8-year study period.

Commotio cordis is among the theories circulating around Buffalo Bills safety Damar Hamlin's on-field cardiac arrest.

Patient Care Guideline Toplines summarize newly revised and updated clinical recommendations from professional societies for convenient, at-a-glance review.

Find a compact sampling of 2022 cardiovascular disease research reviewed on Patient Care, chosen by the editorial staff.

Cardiometabolic disease affects 1 out of every 2 Americans today. This first of 4 quizzes tests your knowledge of how to manage hypertension, heart failure, and renal disease.

Worldwide the report finds that hypertension, hypercholesterolemia, dietary risks, and air pollution are the leading causes of CVD which remains the leading cause of death globally.

Having both conditions while pregnant in the current study conferred more than double the risk of future CVD vs having either condition alone.

Approved in 2020 as Nexletol, bempedoic acid as the first ATP citrate lyase inhibitor and oral non-statin therapy to meet the MACE-4 primary endpoint.